A tumor-node-metastasis (TNM) staging classification system has been developed forÂ gastrointestinal stromal tumors by the Union for International Cancer Control/American Joint Committee on Cancer, however, is not typically used for GISTs, due to its limitations capturing the factors shown to impact prognosis.